Related Experiment Video
Updated: Jun 1, 2026
07:53
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with
F de Graaff1, W Verra, J E H Pruijs
1Department of Orthopaedic Surgery, Wilhelmina Children's Hospital (University Medical Center Utrecht), P.O. Box 85090, 3508 AB Utrecht, The Netherlands.
Journal of Children'S Orthopaedics
|May 20, 2011
Summary
Bisphosphonate treatment significantly reduced outpatient visits and surgeries for children with osteogenesis imperfecta (OI). This study confirms bisphosphonates improve OI management by decreasing healthcare utilization.
Area of Science:
- Pediatric Orthopedics
- Pharmacological Treatments
- Rare Bone Diseases
Background:
- Osteogenesis imperfecta (OI) is a genetic disorder characterized by fragile bones.
- Bisphosphonates are a common medical treatment for OI in pediatric populations.
- Evaluating treatment efficacy is crucial for optimizing patient care and outcomes.
Purpose of the Study:
- To assess the effectiveness of bisphosphonate therapy in children diagnosed with osteogenesis imperfecta.
- To quantify changes in healthcare resource utilization before and after initiating bisphosphonate treatment.
- To provide evidence supporting bisphosphonate use in managing OI.
Main Methods:
- Retrospective pre-post study design.
- Inclusion criteria: at least 2 years of medical records pre- and post-treatment.
- Data collected: frequency of outpatient department consultations and operative interventions.
Main Results:
- A statistically significant reduction in outpatient consultations was observed post-bisphosphonate treatment (P < 0.000).
- Operative intervention frequency also significantly decreased following bisphosphonate therapy (P < 0.003).
- The study included 51 children (23 boys, 28 girls) who met the inclusion criteria.
Conclusions:
- Bisphosphonate treatment leads to a significant decrease in both outpatient consultations and operative interventions for children with OI.
- The findings support the utility of bisphosphonates in reducing the burden of care associated with osteogenesis imperfecta.
- This study highlights the positive impact of bisphosphonates on managing OI in a pediatric cohort.
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:27Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...